Stock 000513 LIVZON PHARMACEUTICAL GROUP INC.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Livzon Pharmaceutical Group Inc.

Equities

000513

CNE0000002Y8

End-of-day quote Shenzhen S.E.
Other stock markets
 23:00:00 04/07/2024 BST 		5-day change 1st Jan Change
37.61 CNY +3.90% Intraday chart for Livzon Pharmaceutical Group Inc. +1.07% +7.43%
06-28 Livzon Pharmaceutical Group Inc. Announces the Final Cash Dividend (A Shares) for 2023, Payable on 08 July 2024 CI
06-28 Livzon Pharmaceutical Group Cancels Repurchased Shares MT

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Livzon Pharmaceutical Group Inc. Announces the Final Cash Dividend (A Shares) for 2023, Payable on 08 July 2024
Livzon Pharmaceutical Group Cancels Repurchased Shares
India's Biocon seeks partner to test generic Wegovy, Ozempic in China
Second Chinese drugmaker seeks approval for Ozempic generic
Sihuan Pharma Subsidiary Licenses Fadanafil Drug to Livzon Pharmaceutical Unit
Chinese drugmakers developing generic drugs of Novo Nordisk's Ozempic
Novo Nordisk braces for generic challenge to Ozempic, Wegovy in China
Livzon Pharmaceutical Cancels 5.3 Million Share Options
Livzon Pharmaceutical Group Cancels Share Options
Livzon Pharmaceutical Declares Final Dividend for 2023
Livzon Pharmaceutical Factory Receives Approval for the U.S. FDA Approval for the Company's Drug Cetrorelix Acetate for Injection
Livzon Pharmaceutical's Q1 Profit Jumps 4.5%; Revenue Slips 5%
Livzon Pharmaceutical Group Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
Livzon Pharma's 2023 Profit Rises 2%; Revenue Falls 2%
Livzon Pharmaceutical Group Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Livzon Pharmaceutical Group Inc. Proposes Final Dividend for the Year Ended December 31, 2023, Payable on 05 August 2024
Livzon Pharma to Trial JP-1366 Tablets as Reflux Esophagitis Drug
Livzon Group Livzon Medical Research Centre Receives Notice of Drug Clinical Trial Approval Issued by China National Medical Products Administration
Livzon Pharma Gets Nod to Trial Weight Management Drug
Livzon Pharmaceutical Appoints Former Joincare Exec as Vice President
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 000513 Stock
  4. News Livzon Pharmaceutical Group Inc.
  5. Other languages